These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25387974)

  • 21. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 906 variations among 27 genes encoding cytochrome P450 (CYP) enzymes and aldehyde dehydrogenases (ALDHs) in the Japanese population.
    Saito S; Iida A; Sekine A; Ogawa C; Kawauchi S; Higuchi S; Ohno M; Nakamura Y
    J Hum Genet; 2002; 47(8):419-44. PubMed ID: 12181643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in molecular modeling of human cytochrome P450 polymorphism.
    Martiny VY; Miteva MA
    J Mol Biol; 2013 Nov; 425(21):3978-92. PubMed ID: 23856621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioinformatics tools for discovery and functional analysis of single nucleotide polymorphisms.
    Li L; Wei D
    Adv Exp Med Biol; 2015; 827():287-310. PubMed ID: 25387971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Streptomyces cytochromes P450: applications in drug metabolism.
    Lamb DC; Waterman MR; Zhao B
    Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1279-94. PubMed ID: 23738914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacogenetic aspects of the activity of cytochromes P450 in the metabolism of antipsychotics].
    Fursa OO; Kozlovskiĭ VL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(4):111-22. PubMed ID: 25089317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of CYP450 single nucleotide polymorphisms with the efficacy of epidural ropivacaine during mastectomy.
    Liu J; Xi H; Jiang Y; Feng Z; Hou L; Li W
    Acta Anaesthesiol Scand; 2015 May; 59(5):640-7. PubMed ID: 25808509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Personalized Medicine and Mood Disorders.
    Alhajji L; Nemeroff CB
    Psychiatr Clin North Am; 2015 Sep; 38(3):395-403. PubMed ID: 26300030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bioinformatics in Cancer Clinical Sequencing -- An Emerging Field of Cancer Personalized Medicine].
    Kato M
    Gan To Kagaku Ryoho; 2016 Apr; 43(4):391-7. PubMed ID: 27220783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tamoxifen, cytochrome P450 genes and breast cancer clinical outcomes.
    Singh MS; Francis PA; Michael M
    Breast; 2011 Apr; 20(2):111-8. PubMed ID: 21185724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The human genome project and novel aspects of cytochrome P450 research.
    Ingelman-Sundberg M
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):52-6. PubMed ID: 15993453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics, epigenetics, and regulation of drug-metabolizing cytochrome p450 enzymes.
    Zanger UM; Klein K; Thomas M; Rieger JK; Tremmel R; Kandel BA; Klein M; Magdy T
    Clin Pharmacol Ther; 2014 Mar; 95(3):258-61. PubMed ID: 24196843
    [No Abstract]   [Full Text] [Related]  

  • 34. Cytochrome P450 enzymes and genotype-guided drug therapy.
    Roederer MW
    Curr Opin Mol Ther; 2009 Dec; 11(6):632-40. PubMed ID: 20072940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interplay of pharmacogenetic variations in ABCB1 transporters and cytochrome P450 enzymes.
    Yoo HD; Lee YB
    Arch Pharm Res; 2011 Nov; 34(11):1817-28. PubMed ID: 22139683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the effects of cytochrome P450 nonsynonymous single-nucleotide polymorphisms on tanshinol borneol ester metabolism and inhibition potential.
    Liu D; Gao Y; Wang H; Zi J; Huang H; Ji J; Zhou R; Nan Y; Wang S; Zheng X; Zhu J; Cui Y; Chen C
    Drug Metab Dispos; 2010 Dec; 38(12):2259-65. PubMed ID: 20736323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DMET microarray technology for pharmacogenomics-based personalized medicine.
    Burmester JK; Sedova M; Shapero MH; Mansfield E
    Methods Mol Biol; 2010; 632():99-124. PubMed ID: 20217574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A single-nucleotide polymorphism tagging set for human drug metabolism and transport.
    Ahmadi KR; Weale ME; Xue ZY; Soranzo N; Yarnall DP; Briley JD; Maruyama Y; Kobayashi M; Wood NW; Spurr NK; Burns DK; Roses AD; Saunders AM; Goldstein DB
    Nat Genet; 2005 Jan; 37(1):84-9. PubMed ID: 15608640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytochrome P450 in Cancer Susceptibility and Treatment.
    Mittal B; Tulsyan S; Kumar S; Mittal RD; Agarwal G
    Adv Clin Chem; 2015; 71():77-139. PubMed ID: 26411412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression Specificity of Disease-Associated lncRNAs: Toward Personalized Medicine.
    Nguyen Q; Carninci P
    Curr Top Microbiol Immunol; 2016; 394():237-58. PubMed ID: 26318140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.